Back

A new era in treatment: cardiac myosin inhibitors

12 June 2025 (16:45 - 17:07)
Organised by: Logo
Congress Presentation Part of: Comprehensive care in hypertrophic cardiomyopathy: diagnosis, treatment strategies, and life beyond the diagnosis Cardiovascular Nursing and Allied Professions ACNAP Premium Access ACNAP Congress 2025 Association of Cardiovascular Nursing and Allied Professions (ACNAP)

About the speaker

Photo
Miss Bethan Cowley

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Accurate diagnosis of hypertrophic cardiomyopathy: recognising red flags
Mrs M. Simpson (Edinburgh, GB)
Slides
Presentation thumbnail
Treatment approaches: medications, procedures, and lifestyle adjustments
Mrs L. Martin (London, GB)
Slides
Presentation thumbnail
Living with hypertrophic cardiomyopathy: managing symptoms, risks, and quality of life
Doctor T. Bueser (London, GB)
Slides

Access the full session

Session thumbnail
Comprehensive care in hypertrophic cardiomyopathy: diagnosis, treatment strategies, and life beyond the diagnosis
Video

The Event

Event poster

ACNAP Congress 2025

12 June 2025 16:45 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model
30 April 2022
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025
thumbnail
Congress Presentation
Cardiac myosin inhibitors use in the real world: what you need to know
30 August 2025
thumbnail
Congress Presentation
Cardiac biomarkers and cardiovascular side effects are associated with a reduced mortality of oncological patients receiving BRAF/MEK-Inhibitor therapy
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources